Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Dose-dependent effects of thyroid hormone on post-ischemic cardiac performance: potential involvement of Akt and ERK signalings.

Mourouzis I, Mantzouratou P, Galanopoulos G, Kostakou E, Roukounakis N, Kokkinos AD, Cokkinos DV, Pantos C.

Mol Cell Biochem. 2012 Apr;363(1-2):235-43. doi: 10.1007/s11010-011-1175-9. Epub 2011 Dec 2.

PMID:
22134702
2.

Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats.

Pantos C, Mourouzis I, Markakis K, Dimopoulos A, Xinaris C, Kokkinos AD, Panagiotou M, Cokkinos DV.

Eur J Cardiothorac Surg. 2007 Aug;32(2):333-9. Epub 2007 Jun 7.

PMID:
17560116
3.

Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation.

Mourouzis I, Giagourta I, Galanopoulos G, Mantzouratou P, Kostakou E, Kokkinos AD, Tentolouris N, Pantos C.

Metabolism. 2013 Oct;62(10):1387-93. doi: 10.1016/j.metabol.2013.05.008. Epub 2013 Jun 15.

PMID:
23773982
4.

Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats.

Pantos C, Mourouzis I, Markakis K, Tsagoulis N, Panagiotou M, Cokkinos DV.

Basic Res Cardiol. 2008 Jul;103(4):308-18. doi: 10.1007/s00395-008-0697-0. Epub 2008 Feb 15.

PMID:
18274800
5.

Thyroid hormone at supra-physiological dose optimizes cardiac geometry and improves cardiac function in rats with old myocardial infarction.

Pantos C, Mourouzis I, Tsagoulis N, Markakis K, Galanopoulos G, Roukounakis N, Perimenis P, Liappas A, Cokkinos DV.

J Physiol Pharmacol. 2009 Sep;60(3):49-56.

6.

Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction.

Kalofoutis C, Mourouzis I, Galanopoulos G, Dimopoulos A, Perimenis P, Spanou D, Cokkinos DV, Singh J, Pantos C.

Mol Cell Biochem. 2010 Dec;345(1-2):161-9. doi: 10.1007/s11010-010-0569-4. Epub 2010 Aug 22.

PMID:
20730619
7.

Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.

Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, Yamada Y, Yamaki T, Sumi S, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S.

J Cardiovasc Pharmacol. 2009 Dec;54(6):510-9. doi: 10.1097/FJC.0b013e3181bfac02.

PMID:
19755919
8.
9.

Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice.

Mourouzis I, Kostakou E, Galanopoulos G, Mantzouratou P, Pantos C.

Mol Cell Biochem. 2013 Jul;379(1-2):97-105. doi: 10.1007/s11010-013-1631-9. Epub 2013 Mar 27.

PMID:
23532677
10.

Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling.

Pantos C, Mourouzis I, Xinaris C, Kokkinos AD, Markakis K, Dimopoulos A, Panagiotou M, Saranteas T, Kostopanagiotou G, Cokkinos DV.

Eur J Endocrinol. 2007 Apr;156(4):415-24.

11.

Enhanced tolerance of the rat myocardium to ischemia and reperfusion injury early after acute myocardial infarction.

Pantos C, Mourouzis I, Dimopoulos A, Markakis K, Panagiotou M, Xinaris C, Tzeis S, Kokkinos AD, Cokkinos DV.

Basic Res Cardiol. 2007 Jul;102(4):327-33. Epub 2007 Feb 8.

PMID:
17285351
13.

Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.

Du J, Zhang L, Wang Z, Yano N, Zhao YT, Wei L, Dubielecka-Szczerba P, Liu PY, Zhuang S, Qin G, Zhao TC.

Am J Physiol Cell Physiol. 2016 Feb 15;310(4):C270-83. doi: 10.1152/ajpcell.00194.2015. Epub 2016 Jan 6.

PMID:
26739490
14.

Thyroid hormone receptor alpha1 downregulation in postischemic heart failure progression: the potential role of tissue hypothyroidism.

Pantos C, Mourouzis I, Galanopoulos G, Gavra M, Perimenis P, Spanou D, Cokkinos DV.

Horm Metab Res. 2010 Sep;42(10):718-24. doi: 10.1055/s-0030-1255035. Epub 2010 Jun 17.

PMID:
20560106
15.

Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.

Henderson KK, Danzi S, Paul JT, Leya G, Klein I, Samarel AM.

Circ Heart Fail. 2009 May;2(3):243-52. doi: 10.1161/CIRCHEARTFAILURE.108.810747. Epub 2009 Mar 25.

16.

Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.

Li GH, Shi Y, Chen Y, Sun M, Sader S, Maekawa Y, Arab S, Dawood F, Chen M, De Couto G, Liu Y, Fukuoka M, Yang S, Da Shi M, Kirshenbaum LA, McCulloch CA, Liu P.

Circ Res. 2009 Apr 10;104(7):896-904. doi: 10.1161/CIRCRESAHA.108.172882. Epub 2009 Feb 26.

17.

Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction.

Takenaka H, Horiba M, Ishiguro H, Sumida A, Hojo M, Usui A, Akita T, Sakuma S, Ueda Y, Kodama I, Kadomatsu K.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H462-9. doi: 10.1152/ajpheart.00733.2008. Epub 2008 Dec 5.

18.

Calpain inhibition preserves myocardial structure and function following myocardial infarction.

Mani SK, Balasubramanian S, Zavadzkas JA, Jeffords LB, Rivers WT, Zile MR, Mukherjee R, Spinale FG, Kuppuswamy D.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1744-51. doi: 10.1152/ajpheart.00338.2009. Epub 2009 Sep 4.

19.

Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.

Morrison A, Yan X, Tong C, Li J.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H895-902. doi: 10.1152/ajpheart.00137.2011. Epub 2011 Jun 10.

20.

[Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].

Wei M, Gu SM, Zhang YY, Wu YH, Wu ZG.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 May;33(5):444-7. Chinese.

PMID:
15932706
Items per page

Supplemental Content

Write to the Help Desk